$AYTU falling wedge monthly Doji candle on support $AYTU looking for a reversal here earning on the 10th of February interesting pipeline could be huge profits to be made
falling wedge forming monthly Doji on support
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.14 USD
−15.84 M USD
81.00 M USD
5.92 M
About Aytu BioPharma, Inc.
Sector
CEO
John A. Donofrio
Headquarters
Englewood
Website
Founded
2002
FIGI
BBG0101PY0G6
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0A8M is 1.55 USD — it has increased by 1.31% in the past 24 hours. Watch AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stocks are traded under the ticker 0A8M.
0A8M stock has fallen by −9.36% compared to the previous week, the month change is a −30.49% fall, over the last year AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) has showed a −35.95% decrease.
We've gathered analysts' opinions on AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) future price: according to them, 0A8M price has a max estimate of 8.00 USD and a min estimate of 8.00 USD. Watch 0A8M chart and read a more detailed AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock forecast: see what analysts think of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) and suggest that you do with its stocks.
0A8M reached its all-time high on Apr 26, 2021 with the price of 142.50 USD, and its all-time low was 1.40 USD and was reached on Jun 29, 2023. View more price dynamics on 0A8M chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0A8M stock is 6.16% volatile and has beta coefficient of 0.91. Track AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) there?
Today AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) has the market capitalization of 9.16 M, it has decreased by −3.87% over the last week.
Yes, you can track AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
0A8M earnings for the last quarter are −0.20 USD per share, whereas the estimation was −0.34 USD resulting in a 41.18% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) earnings.
AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) revenue for the last quarter amounts to 16.57 M USD, despite the estimated figure of 13.77 M USD. In the next quarter, revenue is expected to reach 15.55 M USD.
0A8M net income for the last quarter is 1.47 M USD, while the quarter before that showed −4.62 M USD of net income which accounts for 131.93% change. Track more AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial stats to get the full picture.
No, 0A8M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) EBITDA is 6.17 M USD, and current EBITDA margin is 6.65%. See more stats in AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial statements.
Like other stocks, 0A8M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) stock shows the strong sell signal. See more of AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.